Page last updated: 2024-08-21

2,3-dimethylmaleic anhydride and Breast Cancer

2,3-dimethylmaleic anhydride has been researched along with Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cao, Z; Hua, Z; Li, Y; Liu, R; Liu, Y; Lu, A; Lu, C; Luo, X; Wang, X; Xue, Z; Zhang, Z1
Li, J; Liang, X; Shen, Q; Sun, L; Yang, J; Zhang, J; Zuo, T1

Other Studies

2 other study(ies) available for 2,3-dimethylmaleic anhydride and Breast Cancer

ArticleYear
MTX-PEG-modified CG/DMMA polymeric micelles for targeted delivery of doxorubicin to induce synergistic autophagic death against triple-negative breast cancer.
    Breast cancer research : BCR, 2023, 01-12, Volume: 25, Issue:1

    Topics: Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Female; Humans; Methotrexate; Micelles; Polymers; Triple Negative Breast Neoplasms

2023
Coadministration of chemotherapy and PI3K/Akt pathway treatment with multistage acidity/CathB enzyme-responsive nanocarriers for inhibiting the metastasis of breast cancer.
    Biomaterials science, 2019, Dec-01, Volume: 7, Issue:12

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Carriers; Female; Humans; Indazoles; Maleic Anhydrides; Mice; Nanoparticles; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Polyethyleneimine; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Proto-Oncogene Proteins c-akt; Signal Transduction; Sulfonamides; Xenograft Model Antitumor Assays

2019